Speaker: Dr. Denise Evans. BIO: Dr Denise Evans, is a Principal Researcher at the Health Economics and Epidemiology Research Office, a division of the Wits Health Consortium with more than 10 years research experience focused on optimizing HIV, TB and drug-resistant TB treatment outcomes. She also holds a joint appointment in the School of Clinical Medicine at the University of the Witwatersrand. Her research interests include interventions to improve ART adherence, low cost monitoring of HIV in resource-limited settings (RLS), and evaluations and innovative approaches to improve outcomes, specifically among vulnerable populations such as children, adolescents and young adults living in South Africa. Denise is the principal investigator for the socio-economic sub-study of TB Sequel (http://www.tbsequel.org/), which aims to describe the psycho-social consequences of TB (including the impact of TB on health-related quality of life, psychological distress, and stigma), the economic costs of TB to patients and their households before, during, and after treatment, and the costs incurred by the health system for treating TB.